Latest rheumatoid arthritis Stories
NEW YORK, Jan. 22, 2013 /PRNewswire/ -- The Harris Poll Physician Pulse(SM) survey of American physicians documents the convergence of functional, emotional, and relationship-based attributes in determining the prescription products physicians trust and why. In the latest study, Actonel®, Advair®, Enbrel®, Humira®, Mirena®, and Spiriva® join the ranks of the top branded pharmaceuticals in Harris Interactive's pioneering index of physician trust. To view the multimedia...
Johns Hopkins scientists identify epigenetic changes that referee genetic risk In one of the first genome-wide studies to hunt for both genes and their regulatory "tags" in patients suffering from a common disease, researchers have found a clear role for the tags in mediating genetic risk for rheumatoid arthritis (RA), an immune disorder that afflicts an estimated 1.5 million American adults. By teasing apart the tagging events that result from RA from those that help cause it, the...
MANHASSET, N.Y., Jan. 17, 2013 /PRNewswire-USNewswire/ -- The Royal Swedish Academy of Sciences announced today that Peter K. Gregersen, MD, a scientist at The Feinstein Institute for Medical Research, will receive the prestigious Crafoord Prize for his genetic research in the area rheumatoid arthritis. Dr. Gregersen, center head of the Feinstein Institute's Robert S. Boas Center for Genomics and Human Genetics in Manhasset, NY, will be formally presented with the award on May 2 by...
HILDEN, Germany and GERMANTOWN, Maryland, January 7, 2013 /PRNewswire/ -- - QIAGEN invests in new companion diagnostic being developed by Drug Response Dx that aims to predict efficacy of TNF-alpha inhibitors in rheumatoid arthritis patients - Rights to RET, ROS1 and DEPDC1 biomarkers gained from Insight Genetics offer promise as companion diagnostics in lung cancer - New tests from Inserm for mutations of HSP110 gene...
The Wall Street Journal recently reported that doctors who once championed the use of opioid-based prescriptions are reconsidering their evangelism of drugs like OxyContin, Percocet and Vicodin. Physician’s Technology, LLC is on a mission to remove one billion of these addictive and deadly pills from the streets. Monroe, MI (PRWEB) January 03, 2013 In light of recent reporting by the Wall Street Journal, Physician’s Technology, LLC is renewing its pledge to remove one billion harmful...
INDIANAPOLIS, Jan. 3, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced that Michael P. Heffernan, M.D., a nationally recognized expert in complex medical dermatology, psoriasis and clinical trials, has joined its autoimmune team as distinguished medical fellow. Alisa E. Koch, M.D., a rheumatologist who has won numerous academic awards for her extensive work in rheumatoid arthritis, joined as senior medical fellow. Most recently, Heffernan was in private practice at...
SOUTH SAN FRANCISCO, Calif., Jan. 3, 2013 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, will present an update on the company's product portfolio at the J.P. Morgan Healthcare Conference in San Francisco on January 7, 2013 at 1:30pm Pacific time (see webcast details below). In December 2012, Rigel initiated a Phase 1 clinical study of R348, a topical JAK/SYK inhibitor, as a...
An observational study involving 629 subjects finds rapid, significant, readily-observable improvement in stroke and traumatic brain injury patients following the perispinal administration of Enbrel. (PRWEB) January 02, 2013 Neurological Wellness Center began holding perispinal injection technique training courses in the spring of 2011. Since then physicians, nurses and lay caregivers have come from around the world to their Center in Managua Nicaragua for individualized instructional...
redOrbit Staff & Wire Reports – Your Universe Online Anxiety has often been at least anecdotally linked with health issues, but new research from one US university hospital suggests high levels of neuroticism could actually be good for a person's well-being. As reported previously by Today.com, University of Rochester Medical Center (URMC) post-doctoral fellow Nicholas Turiano has discovered evidence that subjects who described themselves as worriers and who also demonstrated...
The Perispinal Enbrel Injection Procedure that Dramatically Reverses the Cognitive Deficits and Physical Impairments Caused by Alzheimer’s Disease, Stroke and Traumatic Brain Injury is Now Available in a $49 On-Line Course Offered by http://www.neurological-recovery-guide.com (PRWEB) December 19, 2012 Neurological Wellness Center began holding perispinal injection technique training courses in the spring of 2011. Since then physicians, nurses and lay caregivers have come from around...
